DE3925759A1 - Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe - Google Patents

Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe

Info

Publication number
DE3925759A1
DE3925759A1 DE19893925759 DE3925759A DE3925759A1 DE 3925759 A1 DE3925759 A1 DE 3925759A1 DE 19893925759 DE19893925759 DE 19893925759 DE 3925759 A DE3925759 A DE 3925759A DE 3925759 A1 DE3925759 A1 DE 3925759A1
Authority
DE
Germany
Prior art keywords
ace inhibitors
captopril
atheroskleroseprophylaxe
patients
atherosclerosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19893925759
Other languages
German (de)
English (en)
Inventor
Matthias Dr Dr Wicklmayr
Guenther Prof Dr Dietze
Kristian Dr Med Rett
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
THERA PATENT VERWALTUNGS GmbH
Original Assignee
THERA PATENT VERWALTUNGS GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by THERA PATENT VERWALTUNGS GmbH filed Critical THERA PATENT VERWALTUNGS GmbH
Priority to DE19893925759 priority Critical patent/DE3925759A1/de
Priority to EP19900113765 priority patent/EP0411395A3/de
Publication of DE3925759A1 publication Critical patent/DE3925759A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE19893925759 1989-08-03 1989-08-03 Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe Withdrawn DE3925759A1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE19893925759 DE3925759A1 (de) 1989-08-03 1989-08-03 Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe
EP19900113765 EP0411395A3 (en) 1989-08-03 1990-07-18 Use of ace inhibitors for atherosclerosis-prophylaxis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19893925759 DE3925759A1 (de) 1989-08-03 1989-08-03 Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe

Publications (1)

Publication Number Publication Date
DE3925759A1 true DE3925759A1 (de) 1991-02-07

Family

ID=6386477

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19893925759 Withdrawn DE3925759A1 (de) 1989-08-03 1989-08-03 Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe

Country Status (2)

Country Link
EP (1) EP0411395A3 (fr)
DE (1) DE3925759A1 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212165A (en) * 1989-10-23 1993-05-18 E. R. Squibb & Sons, Inc. Method for rehabilitating the vasorelaxant action of the coronary arteries impaired through atherosclerosis or hypercholesterolemia employing an ace inhibitor
US5061694A (en) * 1989-10-23 1991-10-29 E. R. Squibb & Sons, Inc. Method for stabilizing or causing regression of atherosclerosis in coronary arteries employing an ace inhibitor
US5157025A (en) * 1991-04-01 1992-10-20 E. R. Squibb & Sons, Inc. Method for lowering serum cholesterol employing a phosphorus containing ace inhibitor alone or in combination with a cholesterol lowering drug
AU714618B2 (en) * 1996-07-15 2000-01-06 Sankyo Company Limited Medicinal composition
WO2005020984A2 (fr) * 2003-08-29 2005-03-10 Aaipharma Inc. Methode de reduction du stress oxydatif

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3536687A1 (de) * 1985-10-15 1987-04-16 Hoechst Ag Verfahren zur behandlung von atherosklerose, thrombose und der peripheren gefaesskrankheit

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA896851B (en) * 1988-09-14 1990-06-27 Hoffmann La Roche Use of ace-inhibitors

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3536687A1 (de) * 1985-10-15 1987-04-16 Hoechst Ag Verfahren zur behandlung von atherosklerose, thrombose und der peripheren gefaesskrankheit

Also Published As

Publication number Publication date
EP0411395A2 (fr) 1991-02-06
EP0411395A3 (en) 1991-11-13

Similar Documents

Publication Publication Date Title
Karunanayake et al. Oral hypoglycaemic activity of some medicinal plants of Sri Lanka
DE69822665T2 (de) Verwendung von 9-desoxy-2',9-alpha-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen)-13,14-dihydroprostaglandin-f1 zur behandlung von peripheren vaskulären erkrankungen
EP0279382B1 (fr) Moyen contre les verrues
DE3328262C2 (fr)
WO1994020139A1 (fr) Utilisation d'anticorps anti-tnf comme medicament therapeutique de l'insuffisance cardiaque (faiblesse du muscle cardiaque)
EP0586909A2 (fr) Utilisation du C1-inhibiteur pour l'obtention d'un médicament destiné au traitement prophylactique et thérapeutique du capillary leak syndroms et du choc circulatoire
CH661869A5 (de) Arzneimittel zur behandlung der ulkuskrankheit.
DE69420776T2 (de) Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer
DE69730214T2 (de) Zusammensetzung und verfahren zur behandlung von herpes simplex
DE2206570C3 (de) Verwendung von (+)-Catechin
EP0331014A2 (fr) L'utilisation des inhibiteurs de l'enzyme de conversion pour la prophylaxie du diabète
DE3925759A1 (de) Verwendung von ace-inhibitoren fuer die atheroskleroseprophylaxe
EP0668768B1 (fr) Composition permettant de lutter contre les dermatomycoses et leurs agents causals, ainsi que contre la sudation et les odeurs corporelles
DE2037942C2 (de) Arzneimittel enthaltend ein "aktives" Chondroitinsulfat als Wirkstoff zur Verhinderung des Auftretens atherosklerotischer Läsionen und zur Verhinderung des Auftretens von Herzanfällen
DE19633446B4 (de) Arzneimittel mit lipidsenkender Wirkung
EP0211093B1 (fr) Médicament pour le traitement de l'herpès
EP2548564B1 (fr) Produit pharmaceutique, alimentation d'un patient et procédé de réduction du poids
Vuopala et al. Dimethyl Sulfoxide (DMSO) Ointment in the Treatment of Rheumatoid Arthritis: A Double Blind Study
Edirisinghe et al. Effect of Sapa Vireka Choorna on Vibandha (Mala Adassiya/Chronic Constipation)–Series of case studies
DE3780702T2 (de) Verwendung von etodolac zur senkung des blutgehalts an harnsaeure.
DE10247339A1 (de) Psoriasisbehandlung
DE1667891A1 (de) Neue therapeutische Zusammensetzungen mit analgetischer Wirksamkeit
DE4236409C1 (de) Verwendung eines Präparates zur Behandlung von Diabetes mellitus
Osato Beiträge zum Studium der Lymphe III. Mitteilung. Die saccharifizierenden Fermente und der Zuckergehalt
DE4244754C2 (de) Bekämpfung der Erreger von Dermatomykosen in Bekleidungsstücken

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8130 Withdrawal